Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results (Q46835382)
Jump to navigation
Jump to search
scientific article published in January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results |
scientific article published in January 2006 |
Statements
1 reference
Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results (English)
1 reference
Kiat Ruxrungtham
1 reference
Sasisopin Kiertiburanakul
1 reference
Somnuek Sungkanuparph
1 reference
Ammarin Thakkinstian
1 reference
Weerawat Manosuthi
1 reference
Asda Vibhagool
1 reference
Sasivimol Rattanasiri
1 reference
1 January 2006
1 reference
1 reference
20
1 reference
1
1 reference
131-132
1 reference